journal article·2017-04Open access

Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks

Markus Friedemann, Liv Kalbitzer, Sandra Franz, Stephanie Moeller, Matthias Schnabelrauch, Jan‐Christoph Simon, Tilo Pompe, Katja Franke

Advanced Healthcare Materials· Volume 6· Issue 7

Abstract

Dynamic alterations of composition and mechanics of the extracellular matrix are suggested to modulate cellular behavior including plasticity of macrophages (MPhs) during wound healing. In this study, engineered 3D fibrillar matrices based on naturally occurring biopolymers (collagen I, glycosaminoglycans (GAGs)) are used to mimic matrix stiffening as well as modification by sulfated and nonsulfated GAGs at different stages of wound healing. Human MPhs are found to sensitively respond to these microenvironmental cues in terms of polarization toward proinflammatory or wound healing phenotypes over 6 days in vitro. MPhs exhibit a wound healing phenotype in stiffer matrices as determined by protein and gene expression of relevant cytokines (IL10, IL12, and TNFα). Presence of sulfated and nonsulfated GAGs inhibits this polarization effect. Furthermore, control experiments on 2D matrices stress the relevance of using stiffness‐controlled 3D matrices, as MPhs show a reciprocal polarization behavior depending on GAG presence. Hence, the results indicate a strong influence of dimensionality, stiffness, and GAG presence of the biomaterial scaffold on MPh polarization and emphasize the need for matrices closely mimicking the 3D in vivo context with a variable stiffness and GAG composition in in vitro studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Cellular Mechanics and Interactions · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biochemistry Universität Leipzig 04103 Leipzig Germany

Department of Dermatology Venerology and Allergology Universitätsklinikum Leipzig 04103 Leipzig Germany

Biomaterials Department INNOVENT e. V. 07745 Jena Germany

Funding

Deutsche Forschungsgemeinschaft

References (48)

Show source-provided references
1. 10.1038/nrm389710.1038/nrm3897 ↗
2. 10.1126/science.117600910.1126/science.1176009 ↗
3. 10.1242/jcs.02382010.1242/jcs.023820 ↗
4. 10.1038/nrm390810.1038/nrm3908 ↗
5. 10.1002/marc.20120038210.1002/marc.201200382 ↗
6. 10.1038/nrm185810.1038/nrm1858 ↗
7. 10.1016/j.addr.2007.08.00510.1016/j.addr.2007.08.005 ↗
8. 10.1126/science.106482910.1126/science.1064829 ↗
9. 10.1002/bit.2236110.1002/bit.22361 ↗
10. 10.1038/icb.2008.4910.1038/icb.2008.49 ↗
11. 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R ↗
12. 10.1038/nri285210.1038/nri2852 ↗
13. 10.1016/S0002-9610(02)00815-210.1016/S0002-9610(02)00815-2 ↗
14. 10.1038/sj.jid.570070110.1038/sj.jid.5700701 ↗
15. 10.1002/path.413310.1002/path.4133 ↗
16. 10.1038/jid.2015.16710.1038/jid.2015.167 ↗
17. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
18. 10.1016/j.biomaterials.2012.02.03410.1016/j.biomaterials.2012.02.034 ↗
19. 10.12703/P6-1310.12703/P6-13 ↗
20. 10.1038/nri244810.1038/nri2448 ↗
21. 10.1016/j.actbio.2012.11.01610.1016/j.actbio.2012.11.016 ↗
22. 10.1002/jbm.a.3410410.1002/jbm.a.34104 ↗
23. 10.1016/j.biomaterials.2012.02.05010.1016/j.biomaterials.2012.02.050 ↗
24. 10.1007/BF0234477910.1007/BF02344779 ↗
25. 10.1089/ten.tec.2012.000910.1089/ten.tec.2012.0009 ↗
26. 10.1038/nbt105510.1038/nbt1055 ↗
27. 10.1002/marc.20100015510.1002/marc.201000155 ↗
28. 10.1016/j.actbio.2014.02.03610.1016/j.actbio.2014.02.036 ↗
29. 10.1039/C5TB01737H10.1039/C5TB01737H ↗
30. 10.1007/s10856-016-5717-210.1007/s10856-016-5717-2 ↗
31. 10.1529/biophysj.106.09799810.1529/biophysj.106.097998 ↗
32. 10.1016/j.micron.2013.03.00410.1016/j.micron.2013.03.004 ↗
33. 10.1038/nsb0395-20510.1038/nsb0395-205 ↗
34. 10.1007/BF0012217610.1007/BF00122176 ↗
35. 10.1021/am201314710.1021/am2013147 ↗
36. 10.1016/j.immuni.2014.06.00810.1016/j.immuni.2014.06.008 ↗
37. 10.1016/j.semcdb.2009.08.00510.1016/j.semcdb.2009.08.005 ↗
38. 10.1073/pnas.040098310110.1073/pnas.0400983101 ↗
39. 10.1126/science.276.5317.142510.1126/science.276.5317.1425 ↗
40. 10.1016/j.biomaterials.2012.03.03910.1016/j.biomaterials.2012.03.039 ↗
41. 10.1093/protein/gzj01310.1093/protein/gzj013 ↗
42. 10.1182/blood.V96.5.187910.1182/blood.V96.5.1879 ↗
43. 10.1089/ten.tea.2007.026410.1089/ten.tea.2007.0264 ↗
44. 10.1016/j.jconrel.2015.12.05310.1016/j.jconrel.2015.12.053 ↗
45. 10.1021/bm900882710.1021/bm9008827 ↗
46. 10.1016/j.biomaterials.2015.02.02210.1016/j.biomaterials.2015.02.022 ↗
47. 10.1021/bm034071c10.1021/bm034071c ↗
48. 10.1063/1.114397010.1063/1.1143970 ↗